NCT01779375View on ClinicalTrials.gov

RISE Pediatric Medication Study

PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

June 16, 2013

Primary Completion Date

July 12, 2017

Study Completion Date

April 30, 2018

Conditions
PrediabetesType 2 Diabetes
Interventions
DRUG

Metformin

DRUG

Glargine

Trial Locations (4)

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

46202

Indiana University, Indianapolis

80045

Childrens Hospital Colorado, Denver

06511

Yale School of Medicine Pediatric Obesity and Type 2 Diabetes Clinic, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

RISE Study Group

NETWORK

NCT01779375 - RISE Pediatric Medication Study | Biotech Hunter | Biotech Hunter